Vasomotor Syndrome
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women. (NCT06726850) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2024-10-14 |
| Efficacy of Nano-Pso Therapy in Menopause (NCT06432816) | Distribuidora Biolife SA de CV | 2024-02-28 |
| The Effect of Laughter Yoga on Vasomotor Symptoms and Sleep Quality (NCT05859594) | Mersin University | 2023-05-02 |
Track Vasomotor Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.